ASLAN Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Corporate Update

ByAlex Sanchez

ASLAN Pharmaceuticals (Nasdaq: ASLN), a clinical-stage, immunology-focused biopharmaceutical company developing innovative treatments to transform the lives of patients, today announced financial results for the second quarter ended June 30, 2022, and provided an update on recent corporate activities. “This quarter, we advanced our understanding of eblasakimab’s differentiated profile and its role in reducing pruritic neuronal responses…

The Honest Company Reports Second Quarter 2022 Results

ByRoger Castellanos

The Honest Company (NASDAQ: HNST), a digitally native, mission-driven brand focused on leading the clean lifestyle movement, today reported financial results for the three and six months ended June 30, 2022. Highlights Second quarter revenue growth of 5%, led by a 9% increase in diapers and wipes Strategic initiatives remain on track for execution of innovation,…